Loading...
12 budesonide COVID-19 controlled studies, 5 RCTs
49% improvement
for early treatment, RR
0.51
[0.04-7.17]
https://c19early.org/umeta.html
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2+
STOIC
Ramakrish.. (RCT)
82%
0.18 [0.04-0.79]
hosp./ER
2/73
11/73
Improvement, RR [CI]
Treatment
Control
STOIC
Ramakrish.. (RCT)
90%
0.10 [0.01-0.75]
hosp./ER
1/70
10/69
STOIC
Ramakrish.. (RCT)
67%
0.33 [0.15-0.72]
no recov.
7/70
21/69
TOGETHER
Reis (DB RCT)
-200%
3.00 [0.12-73.5]
death
1/738
0/738
CT1
TOGETHER
Reis (DB RCT)
12%
0.88 [0.32-2.40]
hosp.
7/738
8/738
CT1
TOGETHER
Reis (DB RCT)
50%
0.50 [0.25-0.92]
progression
13/738
27/738
CT1
Ramlall (ICU)
71%
0.29 [0.11-0.78]
death
33 (n)
915 (n)
Intubated patients
PRINCIPLE
Yu (RCT)
39%
0.61 [0.22-1.67]
death
6/787
10/799
PRINCIPLE
Yu (RCT)
6%
0.94 [0.44-1.98]
ventilation
13/776
14/784
PRINCIPLE
Yu (RCT)
52%
0.48 [0.23-1.01]
ICU
10/771
21/779
PRINCIPLE
Yu (RCT)
25%
0.75 [0.55-1.03]
death/hosp.
72/787
116/1,069
PRINCIPLE
Yu (RCT)
17%
0.83 [0.74-0.93]
recov. time
787 (n)
1,069 (n)
Al Sulaiman (ICU)
32%
0.68 [0.41-1.13]
death
30/64
31/64
ICU patients MP 80%2
Al Sulaiman (ICU)
47%
0.53 [0.31-0.93]
death
25/65
29/65
ICU patients MP 80%2
Alsultan (RCT)
-7%
1.07 [0.42-2.71]
death
5/14
7/21
TACTIC
Agustí (RCT)
-23%
1.23 [0.08-19.0]
death
1/40
1/49
TACTIC
Agustí (RCT)
39%
0.61 [0.12-3.17]
progression
2/40
4/49
Yang
-11%
1.11 [0.62-1.97]
death
30/125
13/60
Samajdar
58%
0.42 [0.08-2.05]
death
2/50
5/52
CT1
Samajdar
65%
0.35 [0.04-3.22]
ventilation
1/50
3/52
CT1
Samajdar
69%
0.31 [0.09-1.07]
hosp.
3/50
10/52
CT1
Samajdar
29%
0.71 [0.55-0.91]
no recov.
50 (n)
52 (n)
CT1
Samajdar
10%
0.90 [0.80-1.02]
no recov.
50 (n)
52 (n)
CT1
Lee
33%
0.67 [0.42-1.08]
cases
19/1,674
95/5,345
Monserrat .. (PSM)
49%
0.51 [0.28-0.90]
death
n/a
n/a
Loucera
22%
0.78 [0.65-0.92]
death
1,047 (n)
14,921 (n)
Budesonide COVID-19 outcomes
c19 early .org Sep 2023
1 CT: study uses combined treatment 2 MP: multiple medications, percentage budesonide shown
Favors budesonide
Favors control
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit